Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000973

Type of data
NGS (Exome)
NGS (Target Capture)
NGS (RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
703 GB
File formats
  • FASTQ
Research
hum0524
Date published
2025-11-12
Date modified
2025-11-12
DDBJ Search
JGAD000973 (opens in a new tab)
JGA Study
JGAS000831 (opens in a new tab)

Analysis method

WES

Materials and participants
Ovarian cancer (ICD10: C56)
AYA Generation: 6 cases
tumor tissues: 6 samples
  • Health status
    Affected
  • Subject count
    6 (Individual)
Disease
Ovarian cancer (C56)
Sample description
DNAs extracted from tumor tissues
  • Tissue
    Ovary
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V5
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
75 bp
Data use policy
NBDC data sharing policy (JGAP000001)

Targeted DNA sequencing

Materials and participants
Ovarian cancer (ICD10: C56)
non-AYA Generation: 45 cases
tumor tissues: 45 samples
  • Health status
    Affected
  • Subject count
    45 (Individual)
Disease
Ovarian cancer (C56)
Sample description
DNAs extracted from tumor tissues
  • Tissue
    Ovary
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
NCC Oncopanel (114 genes)
https://www.ncc.go.jp/en/information/press_release/2019/0717/index.html
Reagent kit
NCC Oncopanel
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina NextSeq 500
Read type
Paired-end
Read length
75 bp
Data use policy
NBDC data sharing policy (JGAP000001)

RNA-seq

Materials and participants
Ovarian cancer (ICD10: C56)
AYA Generation: 6 cases
tumor tissues: 6 samples
non-AYA Generation: 40 cases
tumor tissues : 40 samples
  • Health status
    Affected
  • Subject count
    46 (Individual)
  • Age group
    Mixed
Disease
Ovarian cancer (C56)
Sample description
RNAs extracted from tumor tissues
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
Illumina Stranded Total RNA Prep, Ligation with Ribo-Zero Plus
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp
Data use policy
NBDC data sharing policy (JGAP000001)